Next Article in Journal
Content of Iron and Vitamin A in Common Foods Given to Children 12–59 Months Old from North Western Tanzania and Central Uganda
Previous Article in Journal
Vitamin B12 in Relation to Oxidative Stress: A Systematic Review
Open AccessArticle

Ergosterol Ameliorates Diabetic Nephropathy by Attenuating Mesangial Cell Proliferation and Extracellular Matrix Deposition via the TGF-β1/Smad2 Signaling Pathway

1
School of Pharmaceutical Sciences, Shandong University, 44 West Wenhua Road, Jinan 250012, Shandong, China
2
School of Basic Medical Sciences, Shandong University, 44 West Wenhua Road, Jinan 250012, Shandong, China
3
Shandong Engineering & Technology Research Center for Jujube Food and Drug, 44 West Wenhua Road, Jinan 250012, Shandong, China
*
Author to whom correspondence should be addressed.
Nutrients 2019, 11(2), 483; https://doi.org/10.3390/nu11020483
Received: 25 January 2019 / Revised: 17 February 2019 / Accepted: 20 February 2019 / Published: 25 February 2019
(1) Background: Diabetic nephropathy, a microvascular complication of diabetes, is one of the principal causes of end-stage renal disease worldwide. The aim of this study was to explore the therapeutic effects of ergosterol on diabetic nephropathy. (2) Methods: Streptozotocin (STZ)-induced C57BL/6 diabetic mice were treated with ergosterol (10, 20, 40 mg/kg/day) for 8 weeks by oral gavage. The in vitro study employed rat mesangial cells exposed to 30 mM glucose for 48 h in the presence of 10 or 20 μM ergosterol. (3) Results: Ergosterol treatment improved body weights, ameliorated the majority of biochemical and renal functional parameters and histopathological changes, and reduced extracellular matrix (ECM) deposition in diabetic mice. In vitro, ergosterol suppressed proliferation, reduced the levels of ECM proteins, and increased the expression of matrix metalloproteinase-2 and -9 in high glucose-induced mesangial cells; Furthermore, ergosterol markedly improved transforming growth factor-β1 (TGF-β1) expression, enhanced phosphorylation levels of drosophila mothers against decapentaplegic 2 (Smad2), and regulated the downstream factors in vivo and in vitro. (4) Conclusions: Ergosterol alleviated mesangial cell proliferation and the subsequent ECM deposition by regulating the TGF-β1/Smad2 signaling pathway. View Full-Text
Keywords: ergosterol; diabetic nephropathy; mesangial cells; ECM; TGF-β1 ergosterol; diabetic nephropathy; mesangial cells; ECM; TGF-β1
Show Figures

Figure 1

MDPI and ACS Style

Dong, Z.; Sun, Y.; Wei, G.; Li, S.; Zhao, Z. Ergosterol Ameliorates Diabetic Nephropathy by Attenuating Mesangial Cell Proliferation and Extracellular Matrix Deposition via the TGF-β1/Smad2 Signaling Pathway. Nutrients 2019, 11, 483.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop